Repare Therapeutics’ Post

attending Esmo, visit this poster to see real implementation of the most comprehensive genomic panel #CGP with better results than TSO500, easy process, and a failure rate less than 5% in routine

Great research and evidence to continuously improve patient care.

Our data at ASCO this year highlights the important role genomic profiling plays in cancer care and research and can be grouped into four major buckets: - Emerging Applications of Liquid Biopsy Using FoundationOne®Liquid CDx and FoundationOne®Tracker. - Utility of CGP in Earlier Stages of Disease, Rare Cancers, and Using RNA Sequencing. - New CGP Biomarkers, Including Homologous Recombination Deficiency (HRD) Signature and Methyl Thioadenosine Phosphorylase (MTAP) Genomic Loss. - Impact of Ancestry on the Genomic Alteration Landscape.

🌟 Exciting news for smaller labs looking to adopt NGS! 🌟 A new cloud-based secondary analysis solution for oncology and inherited disease applications enables labs to process more sequencing data without extensive time and resource investment. Agnostic for use with any panel, scalable to any case volume, and ISO 27001-, GDPR- and HIPAA-compliant, this new secondary analysis solution is breaking speed and cost barriers in #NGS testing. Learn more ⬇️ #Genomics #SmallLabs #Accessibility #GeneticTesting #NGSAnalysis #ClinicalNGS

Ahead of the curve…

Did you know? Next-Generation Sequencing (NGS) in clinical settings has revolutionized personalized medicine by enabling comprehensive genomic analysis in a fraction of the time compared to traditional methods. Efficient analysis and interpretation of NGS data is very much important to get informed decision on disease diagnostics and treatment. Join our upcoming workshop to get answers to all your questions related to NGS and it's applications in Clinic! Hurry up... early bird discount ends on March 12th!! For registration and more details, visit https://lnkd.in/dkVH735N #precisionmedicine #nextgenerationsequencing #bioinformatics

🎉It’s RNA Day!🎉 Let's celebrate U with 50% off select streamlined KAPA RNA HyperPrep Kits! The workflow, including ribodepletion, can now be completed in about 5 hours—making more time for U! Learn more: http://spkl.io/60424i4C4 #DrugDiscovery #RNAseq #PrecisionMedicine #CancerResearch #TranslationalResearch #NGS #LibraryPrep #NextGenSequencing #Sequencing #Genomics For Research Use Only. Not for use in diagnostic procedures.

It is critical that DNA-based genomic profiling (CGP) tests are optimally designed to identify fusions, which are important driver events that can significantly influence treatment decisions & patient outcomes. #NewResearch demonstrates that robust detection of fusions is possible using carefully designed DNA-based sequencing methodologies and, in an analysis of nonsquamous NSCLC, that fusions detected using high-quality DNA CGP assays are associated with clinical benefit from matched targeted agents. Read more in our latest research spotlight: https://bit.ly/49N1x3R

Hot off the presses, our newest case study highlights how RNA-seq can be employed in retrospective clinical trials. Click the link below to read how RNAseq helped uncover a potential biomarker of Selinexor response in DD-LPS patients. If you want to learn more about how the sequencing capabilities at Discovery Life Sciences can aid your clinical studies and research, don't hesitate to reach out. #clinicalresearch #immunooncology #rnaseq #drugdevelopment #clinicaltrials

Implementing comprehensive rapid genomic testing into your diagnostic evaluation can return results—and help you better address your patients’ unique needs—in as little as 5 days. For acutely and critically ill babies, using rapid whole genome sequencing (rWGS) as a first-tier test can influence clinical management, reduce overall healthcare costs, and prevent a diagnostic odyssey. #NICUAwareness #NICUAwarenessMonth #NICUWarriors #NICU #GenomicSequencing #GenomeSequencing #GeneticTesting